AU4719793A - Mixture of a free radical scavenger and an iron chelator for the treatment of sickle cell disease - Google Patents

Mixture of a free radical scavenger and an iron chelator for the treatment of sickle cell disease

Info

Publication number
AU4719793A
AU4719793A AU47197/93A AU4719793A AU4719793A AU 4719793 A AU4719793 A AU 4719793A AU 47197/93 A AU47197/93 A AU 47197/93A AU 4719793 A AU4719793 A AU 4719793A AU 4719793 A AU4719793 A AU 4719793A
Authority
AU
Australia
Prior art keywords
mixture
treatment
free radical
sickle cell
radical scavenger
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47197/93A
Inventor
Catherine Anne Rice-Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of AU4719793A publication Critical patent/AU4719793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47197/93A 1992-08-04 1993-08-02 Mixture of a free radical scavenger and an iron chelator for the treatment of sickle cell disease Abandoned AU4719793A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929216506A GB9216506D0 (en) 1992-08-04 1992-08-04 Improvements in or relating to the treatment of sickle cell disease
GB9216506 1992-08-04
PCT/GB1993/001626 WO1994003169A1 (en) 1992-08-04 1993-08-02 Mixture of a free radical scavenger and an iron chelator for the treatment of sickle cell disease

Publications (1)

Publication Number Publication Date
AU4719793A true AU4719793A (en) 1994-03-03

Family

ID=10719768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47197/93A Abandoned AU4719793A (en) 1992-08-04 1993-08-02 Mixture of a free radical scavenger and an iron chelator for the treatment of sickle cell disease

Country Status (4)

Country Link
AU (1) AU4719793A (en)
GB (2) GB9216506D0 (en)
WO (1) WO1994003169A1 (en)
ZA (1) ZA935647B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT768302E (en) * 1995-09-29 2005-11-30 Novartis Ag NEW HYDROXYPYRIDINONES
US6087398A (en) * 1996-03-01 2000-07-11 South Alabama Medical Science Foundation Sickle cell anemia treatment
IT1312086B1 (en) * 1999-04-21 2002-04-04 Zambon Spa USE OF NAC FOR THE PREPARATION OF A DRUG SUITABLE FOR INTRAVENOUS ADMINISTRATION FOR STRESS PREVENTION
DE10160796A1 (en) * 2001-12-11 2003-06-26 Wulf Droege Use of cysteine or its derivative for increasing tissue oxygen supply, respiratory activity and/or plasma erythropoietin levels, e.g. in cancer or cardio-pulmonary disease patients
EP2362726B1 (en) * 2008-10-14 2018-08-08 Bioelectron Technology Corporation Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
CN102190644B (en) * 2011-03-31 2012-11-21 浙江大学 chiral 3-hydroxypyridine-4-ketone derivative and synthesis and application thereof
EP3960168A1 (en) * 2020-08-28 2022-03-02 Université de Genève Compositions and methods comprising d-cysteine or a derivative thereof

Also Published As

Publication number Publication date
GB9216506D0 (en) 1992-09-16
GB2269748A (en) 1994-02-23
GB9316004D0 (en) 1993-09-15
ZA935647B (en) 1995-02-06
WO1994003169A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
AU7545594A (en) Implantable device for the treatment of aedemas
ZA933133B (en) Application for introducing a cream-type substance into a woman's vagina
AU5188993A (en) Implantable cardioverter-defibrillator having early charging capability
AU8138687A (en) Agents for combating pests and plant treatment agents
ZA935532B (en) Crystalline amifostine compositions and methods for the preparation and use of same
IE890157L (en) 16-dehydro-vitamin d3 - derivatives
AU4896090A (en) Insecticide treatment and compositions therefor
AU5286193A (en) Free active oxygen radical scavenger
AU4719793A (en) Mixture of a free radical scavenger and an iron chelator for the treatment of sickle cell disease
ZA935347B (en) Treatment of solid material
AU1097192A (en) Treatment of particulate material
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU3553489A (en) Novel compounds and treatment
AU3027692A (en) Compositions for the treatment of mammalian diseases
GB9007730D0 (en) Therapeutic compound and composition
IL104755A0 (en) Treatment of glaucoma
AU4581089A (en) N-substituted 2-cyano-3-oxo-3-substituted-proprionamides as anti-inflammatory agents
IL105285A0 (en) Compositions for the treatment of diabetes
ZA932303B (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
AU4081393A (en) Medicaments for the treatment of anxiety
AU8879691A (en) Treatment of dispersions
AU7192994A (en) Formulation for treating silage
AU6432294A (en) Device for the stabilization of the shielding elements of a structure's body
AU664118B2 (en) Process for the agrochemical treatment of grasslands
AU3722593A (en) Compositions for the treatment of glaucoma